Hims & Hers Health, Inc. HIMS
Analyst Ratings
- Consensus
- Hold — 3 Buy · 11 Hold · 0 Sell (14 analysts)
- Avg. Price Target
- $31.58 (+2.1% upside)
Key Stats
- Today's Range
- $28.31 – $31.45
- 50-Day Range
- $26.73 – $34.46
- 52-Week Range
- $13.74 – $65.30
- Volume
- 16.03 million shs
- Average Volume
- 9.84 million shs
- Market Cap
- $7.21 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.44%
- Days to Cover
- 1.00
About Hims & Hers Health, Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Related Stocks
Compare head-to-head: HIMS vs STLN·HIMS vs LFMD·HIMS vs AIRS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.